We read with interest the article by Dehal, Smith and Nash (1), intitled “Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review—past, present and future” and, also congratulating them for the comprehensive review performed, we believe that, the role that hyperthermic intraperitoneal chemotherapy (HIPEC) can play in the prophylaxis of peritoneal carcinomatosis (PC) in patients with gastric cancer, should be emphasized.
Prophylactic hyperthermic intraperitoneal chemotherapy can be considered in the management of advanced gastric cancer
MACRI', Antonio
Primo
;
2016-01-01
Abstract
We read with interest the article by Dehal, Smith and Nash (1), intitled “Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review—past, present and future” and, also congratulating them for the comprehensive review performed, we believe that, the role that hyperthermic intraperitoneal chemotherapy (HIPEC) can play in the prophylaxis of peritoneal carcinomatosis (PC) in patients with gastric cancer, should be emphasized.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
3106485.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
98.33 kB
Formato
Adobe PDF
|
98.33 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
